droldham I publish therefor I am ROBERT K. OLDHAM, M.D. Dr. Robert K. Oldham is an internationally recognized cancer specialist and is regarded as a leading pioneer in the development and use of biotherapy - the fourth modality in cancer treatment. He currently works in Thomasville, Georgia, where he is the CEO of Cancer Therapeutics, Inc. Dr. Oldham attended the University of Missouri where his undergraduate studies were in chemical engineering and pre-medical sciences. He completed his M.D. degree in 1968. During medical school, he was awarded a PHS Student Research Fellowship and two PHS Cancer Clinical Research Fellowships. Dr. Oldham subsequently interned and did his residency in Internal Medicine at the Vanderbilt University Hospital in Nashville, Tennessee. He continued his education with a Medical Oncology Fellowship and graduate studies in immunology at the National Cancer Institute (NCI) in Bethesda, Maryland during 1970-1972. There he served as Clinical Associate in the Radiation Branch and in the Cellular and Tumor Immunology Section of the Laboratory of Cell Biology. Research and active leadership in cancer treatment has been the ongoing focus of Dr. Oldham’s professional life. In 1972, he served as a Research Associate with Professor G. Mathe’ at Hospital Paul Brousse in Villejuif, France, then returned as Senior Investigator in the National Cancer Institute’s Cellular and Tumor Immunology Section of the Laboratory of Immunodiagnosis during 1973-1975. From 1975-1980 he served as Associate Professor of Medicine and Associate Director of the Vanderbilt Cancer Center where he also was Founder and Director of the Division of Oncology. Dr. Oldham returned to the National Cancer Institute from 1980-1984 to serve as Associate Director of the Division of Cancer Treatment and as Founding Director of the Biological Response Modifiers Program. In 1984, Dr. Oldham established the Biological Therapy Institute in Franklin, Tennessee; the Biomedical Research Center at the University of British Columbia (Founder and Consultant); and Biotherapeutics Incorporated (Founder, Scientific Director and Chairman of the Board) in Nashville. Since then, he has also served as Chairman of the Board for Media America, Chairman of the Board and President of American Patient Services, Medical Director of Cancer Treatment Associates, and Chairman of the Board and CEO of Cancer Therapeutics Incorporated. In addition to Dr. Oldham’s current role with Cancer Therapeutics, he is Associate Director of the Singletary Oncology Center in Thomasville, GA and holds a Clinical Professorship in Hematology/Oncology at the University of Missouri-Columbia and a Consulting Professorship in Oncology at Florida State University College of Medicine . Dr. Oldham also serves as Medical Director and Vice President for Business Development for CBA Research in Lexington, Kentucky. Dr. Oldham has received several NCI clinical group appointments including the Lung Cancer and Southeastern Oncology Study Groups. He was the Founder and President of the Society for Biological Therapy and was Founder and Chairman of the Cancer Biotherapy Study Group. He has also acted as consultant to various companies in the US and abroad such as Gen-Cell (Rhône-Poulenc), Jenner Technologies, Wellcome Biotechnology Ltd. and Amersham Corporation in England. More recently, he has been a senior consultant with the American Red Cross, Cell Genesys Inc., Xcyte Therapies and Maxim Pharmaceuticals. Dr. Oldham is the founder and has served as editor-in-chief of three medical journals: Cancer Biotherapy (now Cancer Biotherapy & Radiopharmaceuticals), Molecular Biotherapy, and Journal of Biological Response Modifiers (now Journal of Immunotherapy). He has also served on the editorial boards of three additional journals. He is the editor of Principles of Cancer Biotherapy- the first comprehensive textbook on the fourth modality of cancer treatment. He has authored or edited fifteen books on cancer treatment and research. Additionally, he has contributed over 420 papers to the medical/scientific literature and has presented thousands of abstracts, posters, and lectures at various meetings on cancer research and treatment. Dr. Oldham has received many awards and honors. He holds or has held membership and/or office in 19 professional societies.